SOPHiA GENETICS (SOPH) Total Non-Current Liabilities (2020 - 2025)

SOPHiA GENETICS has disclosed Total Non-Current Liabilities across 6 years of filings, most recently posting $65.4 million for Q4 2025.

• Total Non-Current Liabilities for Q4 2025 came in at $65.4 million, up 104.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $65.4 million (up 104.14% YoY), and the FY2025 annual result was $65.4 million, up 104.14% from the prior year.
• Total Non-Current Liabilities came in at $65.4 million for Q4 2025 at SOPHiA GENETICS, down from $65.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $66.4 million in Q2 2025 to a low of $8.0 million in Q2 2021.
• The 5-year median for Total Non-Current Liabilities is $18.5 million (2023), against an average of $27.8 million.
• Peak annual rise in Total Non-Current Liabilities reached 125.7% in 2022, while the deepest fall reached 4.65% in 2022.
• SOPHiA GENETICS's Total Non-Current Liabilities stood at $16.2 million in 2021, then climbed by 4.5% to $16.9 million in 2022, then climbed by 12.99% to $19.1 million in 2023, then surged by 67.68% to $32.0 million in 2024, then jumped by 104.14% to $65.4 million in 2025.
• The last three Total Non-Current Liabilities figures came in at $65.4 million (Q4 2025), $65.8 million (Q3 2025), and $66.4 million (Q2 2025), per Business Quant data.